<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel>
<title>Veille techno · Biotech &amp; Health Tech</title><link>https://lestontons.tech/veille/</link>
<description>Dernières en Biotech &amp; Health Tech.</description><language>fr</language>
<item>
<title>STAT+: Jury rules in favor of ousted Cambridge scientist David Sabatini, with $6 million in damages to be awarded</title><link>https://www.statnews.com/2026/10/16/david-sabatini-wins-sexual-misconduct-lawsuit-metoo/?utm_campaign=rss</link>
<guid isPermaLink="false">veille techno-1792216894156834</guid>
<pubDate>Sat, 17 Oct 2026 02:38:35 +0000</pubDate>
<description>A Suffolk County jury on Friday awarded $6 million in damages to ousted star scientist and former MIT professor David Sabatini, whose career imploded after he was accused by a much younger colleague of inappropriate sexual conduct in his…</description>
</item>
<item>
<title>Edwards recall of Sapien mitral delivery systems tied to 1 death</title><link>https://www.medtechdive.com/news/edwards-recall-of-sapien-mitral-delivery-systems-tied-to-1-death/833269/</link>
<guid isPermaLink="false">veille techno-1792216894156573</guid>
<pubDate>Fri, 16 Oct 2026 18:59:26 +0000</pubDate>
<description>Edwards is asking customers to return some of the delivery systems used with its Sapien M3 devices after receiving three reports of balloons bursting when inflated during the procedure.</description>
</item>
<item>
<title>Iambic CEO on taking an AI drug company public</title><link>https://www.biopharmadive.com/news/Iambic-ipo-tom-miller-ai-drug-development-discovery/833238/</link>
<guid isPermaLink="false">veille techno-1792216894156405</guid>
<pubDate>Fri, 16 Oct 2026 16:10:00 +0000</pubDate>
<description>Fresh off a $150 million IPO, Tom Miller spoke to BioPharma Dive about the roadshow process and how he sees AI’s role in drug development evolving.</description>
</item>
<item>
<title>Hospitals’ next lucrative bet — longevity clinics</title><link>https://www.statnews.com/2026/10/16/readout-loud-podcast-hospitals-longevity-clinics-northwestern/?utm_campaign=rss</link>
<guid isPermaLink="false">veille techno-1792216894156345</guid>
<pubDate>Fri, 16 Oct 2026 15:34:31 +0000</pubDate>
<description>Longevity medicine is now estimated to be a multitrillion dollar industry. But what are people paying for, and does it work? On this week’s episode of “The Readout LOUD,” STAT’s biotech podcast, we bring on STAT reporter Sarah Todd to…</description>
</item>
<item>
<title>MiniMed completes separation from Medtronic</title><link>https://www.medtechdive.com/news/minimed-completes-separation-from-medtronic/833227/</link>
<guid isPermaLink="false">veille techno-1792163739436959</guid>
<pubDate>Fri, 16 Oct 2026 14:25:39 +0000</pubDate>
<description>Medtronic exchanged all of its remaining shares of the diabetes technology spinoff.</description>
</item>
<item>
<title>STAT+: Up and down the ladder: The latest comings and goings</title><link>https://www.statnews.com/pharmalot/2026/10/16/up-down-ladder-jobs-pharma-biotech-gilead-bausch-sanofi/?utm_campaign=rss</link>
<guid isPermaLink="false">veille techno-1792163739436885</guid>
<pubDate>Fri, 16 Oct 2026 14:00:13 +0000</pubDate>
<description>Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them . Don’t be shy.…</description>
</item>
<item>
<title>STAT+: Pharmalittle: We’re reading about an HHS peptide push, Trump’s pharma stock holdings, and more</title><link>https://www.statnews.com/pharmalot/2026/10/16/hhs-peptide-push-trump-pharma-stock-holdings/?utm_campaign=rss</link>
<guid isPermaLink="false">veille techno-1792163739436854</guid>
<pubDate>Fri, 16 Oct 2026 13:49:21 +0000</pubDate>
<description>And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is, so far, rather modest. We plan to catch up on our reading…</description>
</item>
<item>
<title>STAT+: RevMed’s pancreatic cancer drug nears European approval</title><link>https://www.statnews.com/2026/10/16/biotech-news-revmed-pancreatic-cancer-drug-nears-european-approval/?utm_campaign=rss</link>
<guid isPermaLink="false">veille techno-1792163739436835</guid>
<pubDate>Fri, 16 Oct 2026 13:38:22 +0000</pubDate>
<description>Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. We’re leaving room for popcorn and intrigue tonight: The new A24 documentary, “You Can See Everything,” hits…</description>
</item>
<item>
<title>This week in charts: Moderna’s massive stock run</title><link>https://www.biopharmadive.com/news/biotech-charts-moderna-stock-xbi-roche-china/832886/</link>
<guid isPermaLink="false">veille techno-1792163739436784</guid>
<pubDate>Fri, 16 Oct 2026 13:15:00 +0000</pubDate>
<description>The latest installment in BioPharma Dive’s data visualization-focused series includes a look at Moderna’s meteoric rise in 2026 and a sudden deal surge from Roche.</description>
</item>
<item>
<title>AMA releases governance framework for agentic AI in healthcare</title><link>https://www.medtechdive.com/news/ama-releases-governance-framework-for-agentic-ai-in-healthcare/833208/</link>
<guid isPermaLink="false">veille techno-1792163739436743</guid>
<pubDate>Fri, 16 Oct 2026 13:00:00 +0000</pubDate>
<description>Industry groups have worked to release guidance on artificial intelligence-backed agents in the absence of federal regulation.</description>
</item>
<item>
<title>What to read before you go see that new documentary on Elizabeth Holmes</title><link>https://www.statnews.com/2026/10/16/health-news-what-to-read-before-elizabeth-holmes-you-can-see-everything/?utm_campaign=rss</link>
<guid isPermaLink="false">veille techno-1792163739436700</guid>
<pubDate>Fri, 16 Oct 2026 12:34:03 +0000</pubDate>
<description>Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here . Happy Friday from sunny San Diego. This is Jonathan Wosen, West Coast biotech &amp; life sciences reporter. We’ve got a strong…</description>
</item>
<item>
<title>Next-gen RNAi drugmaker City prices $200M IPO</title><link>https://www.biopharmadive.com/news/city-therapeutics-ipo-price-rnai-drugs/832945/</link>
<guid isPermaLink="false">veille techno-1792163739436485</guid>
<pubDate>Fri, 16 Oct 2026 10:33:00 +0000</pubDate>
<description>The offering will support a trio of medicines in or nearing clinical testing, as well as earlier research into RNAi treatments that get into tissues outside the liver.</description>
</item>
<item>
<title>Biogen-backed Estuary nabs $93M for kidney disease gene therapy</title><link>https://www.biopharmadive.com/news/estuary-kidney-disease-gene-therapy-launch-emerged-biogen-biotech-startup/833114/</link>
<guid isPermaLink="false">veille techno-1792163739436476</guid>
<pubDate>Fri, 16 Oct 2026 10:30:00 +0000</pubDate>
<description>The Series A round, which was led by RA Capital, will help fund the development of two genetic medicines designed to treat an inherited kidney disorder known as &quot;ADPKD.&quot;</description>
</item>
<item>
<title>Opinion: I thought I knew why patients stopped taking their medicine. I was wrong</title><link>https://www.statnews.com/2026/10/16/nonadherence-medication-stopped-identity-pharmacist-side-effects-prevent/?utm_campaign=rss</link>
<guid isPermaLink="false">veille techno-1792163739436287</guid>
<pubDate>Fri, 16 Oct 2026 08:30:00 +0000</pubDate>
<description>During my years as a clinical pharmacist, I thought I understood why patients stopped taking long-term medications — one of the biggest challenges in medicine. They forgot to take them, became frustrated with side effects, or didn’t fully…</description>
</item>
<item>
<title>Opinion: Is Milton Friedman to blame for America’s health care woes?</title><link>https://www.statnews.com/2026/10/16/neoliberalism-health-care-milton-friedman-john-mcdonough-stuart-butler-debate/?utm_campaign=rss</link>
<guid isPermaLink="false">veille techno-1792163739436288</guid>
<pubDate>Fri, 16 Oct 2026 08:30:00 +0000</pubDate>
<description>Welcome to Friendly Argument, a new STAT First Opinion series in which two experts who disagree but respect each other’s point of view engage in a debate about medicine and health policy. In this installment, John E. McDonough , author of…</description>
</item>
<item>
<title>STAT+: In DOGE’s aftermath, federal health workers bristle at new performance reviews</title><link>https://www.statnews.com/2026/10/16/federal-performance-reviews-health-agency-employees-wary-after-doge/?utm_campaign=rss</link>
<guid isPermaLink="false">veille techno-1792163739436289</guid>
<pubDate>Fri, 16 Oct 2026 08:30:00 +0000</pubDate>
<description>WASHINGTON — Changes to the annual performance review process are the latest flashpoint in tensions between federal workers across the Department of Health and Human Services and the Trump administration, federal employees told STAT. Staff…</description>
</item>
<item>
<title>STAT+: Coerced sex or a jealous ex? Jury weighs dueling accounts of star scientist David Sabatini’s downfall</title><link>https://www.statnews.com/2026/10/16/david-sabatini-civil-trial-highlights-permissive-sexual-norms-whitehead-metoo/?utm_campaign=rss</link>
<guid isPermaLink="false">veille techno-1792163739436290</guid>
<pubDate>Fri, 16 Oct 2026 08:30:00 +0000</pubDate>
<description>Was world-renowned molecular biologist David Sabatini a manipulative mentor who coerced a younger colleague into sex and cultivated a hostile work culture at his research lab in Cambridge? Or was he the victim of a spurned former lover and…</description>
</item>
<item>
<title>EndoQuest Robotics hires chief commercial officer</title><link>https://www.medtechdive.com/news/endoquest-robotics-hires-chief-commercial-officer/833200/</link>
<guid isPermaLink="false">veille techno-1792163739436264</guid>
<pubDate>Fri, 16 Oct 2026 08:03:04 +0000</pubDate>
<description>Jared Eben joins EndoQuest ahead of the anticipated launch of its flexible robotic surgery system.</description>
</item>
<item>
<title>Trump administration advances plan for peptide drugs favored by RFK Jr.</title><link>https://www.statnews.com/2026/10/15/trump-administration-advances-plan-peptides-rfk-jr/?utm_campaign=rss</link>
<guid isPermaLink="false">veille techno-1792130487227105</guid>
<pubDate>Thu, 15 Oct 2026 20:46:09 +0000</pubDate>
<description>WASHINGTON — U.S. health officials are moving ahead with a plan to allow specialty pharmacies to produce certain peptides , a class of largely unregulated injections that have become popular among followers of Health Secretary Robert F.…</description>
</item>
<item>
<title>Merck and Moderna have ‘lot of exploring to do’ after initial cancer vaccine success</title><link>https://www.statnews.com/2026/10/15/moderna-merck-keytruda-mrna-cancer-vaccine-strategy/?utm_campaign=rss</link>
<guid isPermaLink="false">veille techno-1792130487227070</guid>
<pubDate>Thu, 15 Oct 2026 19:58:35 +0000</pubDate>
<description>After public school teacher Gary Keblish was diagnosed with melanoma in 2019, a surgeon cut out the tumor. But he wasn’t out of the woods. In some patients, melanoma aggressively recurs after surgery, so his doctors referred him to a new…</description>
</item>
<item>
<title>Accelerate the timeline from gene to lead cline with new GS Ori-Go® vector</title><link>https://www.fiercebiotech.com/resource/accelerate-timeline-gene-lead-cline-new-gs-ori-gor-vector</link>
<guid isPermaLink="false">veille techno-1792130487227006</guid>
<pubDate>Thu, 15 Oct 2026 18:29:25 +0000</pubDate>
<description>Accelerate the timeline from gene to lead cline with new GS Ori-Go® vector Drug developers face tremendous pressure to increase efficiency and productivity, and reduce development timelines. At Lonza, focused innovation efforts aimed at…</description>
</item>
<item>
<title>The Trump administration is doubling down on health care fraud investigations</title><link>https://www.statnews.com/2026/10/15/healthcare-fraud-new-doj-policy-rewards-self-disclosure/?utm_campaign=rss</link>
<guid isPermaLink="false">veille techno-1792130487226988</guid>
<pubDate>Thu, 15 Oct 2026 18:09:18 +0000</pubDate>
<description>The Department of Justice has a warning for health care executives: Don’t be another Theranos. As the Trump administration continues its fight against Medicare and Medicaid fraud, it is also expanding its investigations into corporate…</description>
</item>
<item>
<title>Mass. lawmaker Auchincloss favors boosting U.S. biotech over targeting China</title><link>https://www.statnews.com/2026/10/15/auchincloss-us-biotech-vs-china-protectionism/?utm_campaign=rss</link>
<guid isPermaLink="false">veille techno-1792130487226941</guid>
<pubDate>Thu, 15 Oct 2026 17:19:50 +0000</pubDate>
<description>Rep. Jake Auchincloss (D-Mass.) has some advice for fellow lawmakers: unapologetically support the biotech industry, vilify insurance companies, and focus on making America a biotech research haven, instead of relying on protectionism.…</description>
</item>
<item>
<title>Cracking complexity: Leveraging lessons learned for future bispecific development</title><link>https://www.fiercebiotech.com/resource/cracking-complexity-leveraging-lessons-learned-future-bispecific-development</link>
<guid isPermaLink="false">veille techno-1792130487226880</guid>
<pubDate>Thu, 15 Oct 2026 16:22:42 +0000</pubDate>
<description>Cracking complexity: Leveraging lessons learned for future bispecific development The biologics pipeline is becoming increasingly complex as next-generation antibody formats, including bispecific antibodies (BsAbs), move rapidly toward the…</description>
</item>
<item>
<title>Belgian startup revives Galapagos CAR-T research</title><link>https://www.biopharmadive.com/news/lakefront-armed-cell-therapies-deal-stoffels-galapagos/833082/</link>
<guid isPermaLink="false">veille techno-1792130487226819</guid>
<pubDate>Thu, 15 Oct 2026 15:55:00 +0000</pubDate>
<description>Armed Cell Therapeutics, chaired by former Galapagos CEO Paul Stoffels, has assumed control of cell therapies the company — now known as Lakefront Biotherapeutics — divested in a strategic overhaul.</description>
</item>
<item>
<title>NEJM study supports CGM use for people with diabetes who don’t take insulin</title><link>https://www.medtechdive.com/news/nejm-study-supports-cgm-use-for-people-with-diabetes-who-dont-take-insulin/833124/</link>
<guid isPermaLink="false">veille techno-1792130487226816</guid>
<pubDate>Thu, 15 Oct 2026 15:53:37 +0000</pubDate>
<description>The results come as Dexcom is awaiting a decision from the Centers for Medicare and Medicaid Services to expand Medicare coverage of the devices for people with Type 2 diabetes.</description>
</item>
<item>
<title>STAT+: Former FDA commissioners Califf, Gottlieb, Sharpless lay into current HHS leadership</title><link>https://www.statnews.com/2026/10/15/health-policy-news-fda-califf-gottlieb-sharpless-criticize-hhs-leadership/?utm_campaign=rss</link>
<guid isPermaLink="false">veille techno-1792130487226813</guid>
<pubDate>Thu, 15 Oct 2026 15:50:58 +0000</pubDate>
<description>You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. It’s the last day of the STAT…</description>
</item>
<item>
<title>STAT+: Verastem’s KRAS inhibitor shows promise in pancreatic cancer</title><link>https://www.statnews.com/2026/10/15/biotech-news-verastem-kras-inhibitor-shows-promise-in-pancreatic-cancer/?utm_campaign=rss</link>
<guid isPermaLink="false">veille techno-1792130487226799</guid>
<pubDate>Thu, 15 Oct 2026 15:43:15 +0000</pubDate>
<description>Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. I, too, wanted to express how devastated I am over losing our colleague Helen Branswell . She was kind, scrupulous…</description>
</item>
<item>
<title>After a melanoma diagnosis, mRNA cancer vaccine delivered a patient hope — and a path forward</title><link>https://www.statnews.com/2026/10/15/melanoma-diagnosis-mrna-cancer-vaccine-stat-summit-boston-2026/?utm_campaign=rss</link>
<guid isPermaLink="false">veille techno-1792130487226770</guid>
<pubDate>Thu, 15 Oct 2026 15:25:08 +0000</pubDate>
<description>When drugmakers Merck and Moderna announced promising results in August from a late-stage trial of adding an mRNA cancer vaccine to immunotherapy, it was heralded as potentially powerful new way of fighting tumors. But the data don’t show…</description>
</item>
<item>
<title>FDA ‘reset’ continues with new plan for reviewing rare disease drugs</title><link>https://www.biopharmadive.com/news/fda-rare-disease-framework-initiative-drug-development/833080/</link>
<guid isPermaLink="false">veille techno-1792130487226768</guid>
<pubDate>Thu, 15 Oct 2026 15:23:00 +0000</pubDate>
<description>A revamped regulatory framework may give investors less of a “guessing game” as they weigh chances for drug approvals, one analyst said.</description>
</item>
<item>
<title>Labcorp to buy BioReference assets for up to $872M</title><link>https://www.medtechdive.com/news/labcorp-to-buy-bioreference-assets-for-up-to-872m/833116/</link>
<guid isPermaLink="false">veille techno-1792130487226760</guid>
<pubDate>Thu, 15 Oct 2026 15:18:59 +0000</pubDate>
<description>Labcorp will pick up specialty testing in women’s health as well as a blood test that assesses the likelihood of finding aggressive prostate cancer before a biopsy decision.</description>
</item>
<item>
<title>Zimmer and Think Surgical pen multi-year extension to robotic surgery deal</title><link>https://www.medtechdive.com/news/zimmer-and-think-surgical-pen-multi-year-extension-to-robotic-surgery-deal/833074/</link>
<guid isPermaLink="false">veille techno-1792130487226724</guid>
<pubDate>Thu, 15 Oct 2026 15:00:00 +0000</pubDate>
<description>Zimmer distributes an exclusive version of Think’s wireless handheld miniature robotic system that works with its Persona knee system.</description>
</item>
<item>
<title>STAT+: Pharmalittle: We’re reading about former FDA head calling DOGE a ‘disaster,’ an AstraZeneca AI deal, and more</title><link>https://www.statnews.com/pharmalot/2026/10/15/former-fda-commissioner-califf-criticized-doge-astrazeneca-ai-deal/?utm_campaign=rss</link>
<guid isPermaLink="false">veille techno-1792130487226585</guid>
<pubDate>Thu, 15 Oct 2026 13:31:56 +0000</pubDate>
<description>Top of the morning to you. And a fine one it is. Lots of sunshine and clear blue skies are greeting us as we prepare for another day on the road, which means we are as busy as ever hunting and gathering items of interest, as well as an…</description>
</item>
<item>
<title>STAT+: ‘AI sandboxes’ are all the rage. Advocates scramble to control their future</title><link>https://www.statnews.com/2026/10/15/scramble-to-shape-regulations-around-state-ai-sandboxes-health-tech/?utm_campaign=rss</link>
<guid isPermaLink="false">veille techno-1792130487226562</guid>
<pubDate>Thu, 15 Oct 2026 13:14:37 +0000</pubDate>
<description>Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday. Good morning health tech readers! Day…</description>
</item>
<item>
<title>Kenya reports second Ebola case</title><link>https://www.statnews.com/2026/10/15/health-news-kenya-reports-second-ebola-case/?utm_campaign=rss</link>
<guid isPermaLink="false">veille techno-1792130487226464</guid>
<pubDate>Thu, 15 Oct 2026 11:55:17 +0000</pubDate>
<description>Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here . Missed the first day of Summit, but want to tune into day two? Register here . Read the rest…</description>
</item>
<item>
<title>STAT+: On Wall Street, there’s trouble stirring for biotech</title><link>https://www.statnews.com/2026/10/15/wall-street-biotech-trouble-stirring/?utm_campaign=rss</link>
<guid isPermaLink="false">veille techno-1792130487226354</guid>
<pubDate>Thu, 15 Oct 2026 10:30:00 +0000</pubDate>
<description>This story first appeared in Adam’s Biotech Scorecard, a STAT newsletter. Sign up here to get it delivered to your inbox. And subscribe to STAT+ to get an unabridged version, with exclusive content. Biotech investors were happy with the…</description>
</item>
<item>
<title>Opinion: My daughter’s death changed how I understood the nursing shortage</title><link>https://www.statnews.com/2026/10/15/nursing-shortage-workforce-direct-support-home-care-workers-group-home/?utm_campaign=rss</link>
<guid isPermaLink="false">veille techno-1792130487226208</guid>
<pubDate>Thu, 15 Oct 2026 08:30:00 +0000</pubDate>
<description>I have spent my career studying nurses and why that workforce so often fails the people it is meant to serve. But my understanding of the system changed deeply the day my daughter died . She was 21 years old. She had intellectual and…</description>
</item>
<item>
<title>Opinion: MyChart said I could opt out of sharing my health data. Figuring out how was maddening</title><link>https://www.statnews.com/2026/10/15/health-data-privacy-medical-record-opt-out-barriers-investigated/?utm_campaign=rss</link>
<guid isPermaLink="false">veille techno-1792130487226209</guid>
<pubDate>Thu, 15 Oct 2026 08:30:00 +0000</pubDate>
<description>STAT is co-publishing this investigation by CalMatters / The Markup . Shira Fischer, a physician who works in health policy in Boston, sought a speech pathologist for her child in 2022, when virtual appointments became the norm because of…</description>
</item>
<item>
<title>Forty percent of high school students report binge eating in new CDC survey</title><link>https://www.statnews.com/2026/10/15/teenage-binge-eating-cdc-survey-finds-alarming-rate/?utm_campaign=rss</link>
<guid isPermaLink="false">veille techno-1792130487226210</guid>
<pubDate>Thu, 15 Oct 2026 08:30:00 +0000</pubDate>
<description>About 40% of high school students reported binge eating in the past month in a large new government survey , putting a spotlight on how widespread this common form of disordered eating is among young people in the U.S. This is the first…</description>
</item>
<item>
<title>Iambic, an AI drug discovery specialist, banks $150M in an IPO</title><link>https://www.biopharmadive.com/news/iambic-ipo-price-ai-drug-discovery/832771/</link>
<guid isPermaLink="false">veille techno-1792044076866458</guid>
<pubDate>Thu, 15 Oct 2026 00:08:00 +0000</pubDate>
<description>Part of a wave of young biotechs employing AI to accelerate research, the company claimed in regulatory filings that its approach has the potential to “disrupt legacy drug discovery paradigms.”</description>
</item>
<item>
<title>Compass Pathways CEO: Psychedelics company will ‘go slow before we go fast’</title><link>https://www.statnews.com/2026/10/14/compass-pathways-psychedelics-stat-summit/?utm_campaign=rss</link>
<guid isPermaLink="false">veille techno-1792044076866457</guid>
<pubDate>Thu, 15 Oct 2026 00:01:24 +0000</pubDate>
<description>The CEO of Compass Pathways said Wednesday that the company, which is preparing to complete the submission of its psychedelic therapy for regulatory review this quarter, will “go slow before we go fast,” warning that negative patient or…</description>
</item>
<item>
<title>Structural variant detection across sequencing technologies</title><link>https://www.nature.com/articles/s41587-026-03332-9</link>
<guid isPermaLink="false">veille techno-1792130487226050</guid>
<pubDate>Thu, 15 Oct 2026 00:00:00 +0000</pubDate>
<description>Nature Biotechnology, Published online: 15 October 2026; doi:10.1038/s41587-026-03332-9 HitSV models the interaction between genomic repetitiveness and signature intensity to improve structural variant detection.</description>
</item>
<item>
<title>Former FDA officials blast DOGE as ‘one of the biggest disasters in American history’</title><link>https://www.statnews.com/2026/10/14/former-fda-commissioners-say-recruit-defend-support-agency-workforce/?utm_campaign=rss</link>
<guid isPermaLink="false">veille techno-1792044076866445</guid>
<pubDate>Wed, 14 Oct 2026 23:23:20 +0000</pubDate>
<description>BOSTON — Three former Food and Drug Administration chiefs lit into the Trump administration Wednesday, criticizing the now former FDA officials who oversaw a massive staffing exodus and saying they robbed the agency of institutional…</description>
</item>
<item>
<title>As White House shifts focus toward AI and tech, U.S. science leaders defend role of the American university</title><link>https://www.statnews.com/2026/10/14/american-science-funding-university-industry-shift-stat-summit-boston-2026/?utm_campaign=rss</link>
<guid isPermaLink="false">veille techno-1792044076866428</guid>
<pubDate>Wed, 14 Oct 2026 22:13:33 +0000</pubDate>
<description>BOSTON — This fall, the Massachusetts Institute of Technology, where 95% of students are STEM majors, enrolled nearly 500 fewer graduate students — a 20% drop compared to 2024. The reduction is a direct result of a $100 million cut in…</description>
</item>
<item>
<title>STAT+: Trump administration delays new rule that could restrict imported medicines from Canada and overseas</title><link>https://www.statnews.com/pharmalot/2026/10/14/trump-administration-delays-new-rule-that-could-restrict-imported-meds-from-canad-and-overseas/?utm_campaign=rss</link>
<guid isPermaLink="false">veille techno-1792044076866363</guid>
<pubDate>Wed, 14 Oct 2026 20:16:59 +0000</pubDate>
<description>The Trump administration is delaying by 90 days a federal rule that could prevent Americans from obtaining prescription drugs from licensed international pharmacies. The move follows growing criticism that the rule, which was initially…</description>
</item>
<item>
<title>How consumer tech company Whoop is building for Medicare patients</title><link>https://www.statnews.com/2026/10/14/whoop-ami-bhatt-population-health-stat-summit-boston-2026/?utm_campaign=rss</link>
<guid isPermaLink="false">veille techno-1792044076866272</guid>
<pubDate>Wed, 14 Oct 2026 18:16:08 +0000</pubDate>
<description>Whoop has never been known for marketing to an older population. Performance athletes headline ads for the wearable company, which aims to turn continuous streams of physiological data into useful insights for behavior change — mostly, for…</description>
</item>
<item>
<title>Experimental Arrowhead RNAi drug hints at Alzheimer’s benefit</title><link>https://www.biopharmadive.com/news/arrowhead-rnai-alzheimers-tau-aro-mapt-study-results/832950/</link>
<guid isPermaLink="false">veille techno-1792044076866098</guid>
<pubDate>Wed, 14 Oct 2026 15:54:00 +0000</pubDate>
<description>In a first, a subcutaneously administered RNA interference medicine crossed into the brain and plummeted levels of a protein implicated in the disease.</description>
</item>
<item>
<title>Verastem cancer drug shows early promise in small study</title><link>https://www.biopharmadive.com/news/verastem-g12d-pancreatic-cancer-results-genfleet/832952/</link>
<guid isPermaLink="false">veille techno-1792044076866027</guid>
<pubDate>Wed, 14 Oct 2026 15:00:00 +0000</pubDate>
<description>Wall Street analysts believe Verastem’s drug to now be “competitive” in what’s quickly become one of the most active and crowded areas of oncology research.</description>
</item>
<item>
<title>Siemens Healthineers to stop selling general ultrasound systems</title><link>https://www.medtechdive.com/news/siemens-healthineers-to-stop-selling-general-ultrasound-systems/832976/</link>
<guid isPermaLink="false">veille techno-1792044076866023</guid>
<pubDate>Wed, 14 Oct 2026 14:53:19 +0000</pubDate>
<description>In a strategy shift, the company will invest in its procedural ultrasound business, supporting cardiovascular surgeries</description>
</item>
<item>
<title>CVS to pay $315M to settle opioid prescribing allegations</title><link>https://www.biopharmadive.com/news/cvs-pay-315-million-settle-opioid-prescribing-allegations/832999/</link>
<guid isPermaLink="false">veille techno-1792044076866016</guid>
<pubDate>Wed, 14 Oct 2026 14:45:52 +0000</pubDate>
<description>Prosecutors say the company filled unnecessary prescriptions that fueled the opioid epidemic. A spokesperson for CVS said the company admitted to no wrongdoing and “strongly disagreed” with the case’s claims.</description>
</item>
</channel></rss>